![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]()
UPI Correspondent Davis, Calif. (UPI) Aug 29, 2006 An enzyme inhibitor found by U.S. scientists looking for biological pest controls may lead to pain relief for sufferers of arthritis and other diseases. The finding by scientists at the University of California-Davis has been hailed by a noted inflammatory disease expert "as the most important discovery in inflammation in more than a decade." It might also reduce side effects associated with the painkiller, Vioxx. Lead author Kara Schmelzer, a post-doctoral researcher in principal investigator Bruce Hammock's lab, tested the novel compounds on rodents and found them to be as potent at a low-dose as Vioxx and Celebrex, but without the changes in blood chemistry linked to heart attacks. Vioxx and Celebrex belong to a class of drugs known as Cox-2 inhibitors. The enzyme targeted by the newly discovered inhibitors is also found in humans. "The reason this is so exciting is that this is a novel way to reduce inflammation, with a combination therapy," Schmelzer said. "We're going after a new enzyme target, not going after the Cox-2 inhibitors." The research is reported in the current edition of Proceedings of the National Academy of Sciences.
Source: United Press International Community Email This Article Comment On This Article Related Links Hospital and Medical News at InternDaily.com Hospital and Medical News at InternDaily.com
![]() ![]() Some 46.6 million Americans now lack health insurance coverage, and as the employer-based system erodes, government safety-net programs are increasingly picking up the slack, according to Census data released Tuesday. |
![]() |
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2006 - SpaceDaily.AFP and UPI Wire Stories are copyright Agence France-Presse and United Press International. ESA PortalReports are copyright European Space Agency. All NASA sourced material is public domain. Additionalcopyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by SpaceDaily on any Web page published or hosted by SpaceDaily. Privacy Statement |